Mohammad Hasibur Rahman is a pharmacist who is specialized in Oncology in Birmingham, Alabama. Patients can reach him at 1700 6th Ave S, Birmingham or contact him on 205-975-2381. Active license number of Mohammad Hasibur Rahman is 17546 for Oncology in Alabama. Mohammad Hasibur Rahman is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Mohammad Hasibur Rahman speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Mohammad Hasibur Rahman
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Male
Location:
1700 6th Ave S, Birmingham, Alabama, 35233-1802
Phone:
205-975-2381
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mohammad Hasibur Rahman are as mentioned below.
NPI Number:
1811584592
NPI Enumeration Date:
28 Dec, 2020
NPI Last Update On:
28 Dec, 2020
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mohammad Hasibur Rahman are as mentioned below.
Specialization
License Number
State
Status
Oncology
17546
Alabama
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1700 6th Ave S, Birmingham, Alabama
Zip:
35233-1802
Phone Number:
--
Fax Number:
--
Patients can reach Mohammad Hasibur Rahman at 1700 6th Ave S, Birmingham, Alabama or can call on phone at 205-975-2381.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.